fr

EN DE

fr

EN DE

Publications

2108 PUBLICATIONS - effacer la recherche

ANNÉE

JOURNAL

PREMIER AUTEUR

TITRE

2022

Cancers

Lemesle M

CLDN1 Sensitizes Triple-Negative Breast Cancer Cells to Chemotherapy.

2022

Advances in biological regulation

Wolf A

Phospholipase D and cancer metastasis: A focus on exosomes.

2022

Frontiers in oncology

Debernardi A

Prognostic role of HPV integration status and molecular profile in advanced anal carcinoma: An ancillary study to the epitopes-HPV02 trial.

2022

Clinical breast cancer

Martin S

Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 Outbreak.

2022

Acta oncologica (Stockholm, Sweden)

Longo R

Is the TCH-P regimen active in early or locally advanced HER2-positive breast cancer? Results of a retrospective study.

2022

Cancer medicine

El Alaoui-Lasmaili K

Fertility discussions and concerns in childhood cancer survivors, a systematic review for updated practice.

2022

Advanced healthcare materials

Brion A

Red Light-Responsive Upconverting Nanoparticles for Quantitative and Controlled Release of a Coumarin-Based Prodrug.

2022

Cancer research

Gambi G

The lncRNA LENOX interacts with RAP2C to regulate metabolism and promote resistance to MAPK inhibition in melanoma.

2022

Critical reviews in oncology/hematology

Faivre JC

AFSOS-SFRO-SFH-SFNEP-SFCE-GFRP guidelines on radio-induced nausea and vomiting.

2022

Pharmaceutics

Dirheimer L

Quantum Dots Mediated Imaging and Phototherapy in Cancer Spheroid Models: State of the Art and Perspectives.